InvestorsHub Logo
icon url

Whalatane

10/19/22 8:07 PM

#391214 RE: ralphey #391209

Well you are primary care
Vascepa is secondary prevention for most …R-IT trial was 70 % secondary prevention.

Why are U stunned by lack of interest in primary prevention ?

Name a clinical trial with US patients using Vascepa for primary prevention. .

Kiwi